CLBX.LSE CelLBxHealth plc

Healthcare Life Sciences Tools & Services London Exchange
0.0060 GBX
Close of Oct 31, 2026
0.5330 2.80
Market cap
GBX 6.82M
P/E
-
P/B
1.66x
ROE
-271.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is CLBX.LSE undervalued?

Graham number

The Graham number of CelLBxHealth plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CelLBxHealth plc fundamental analysis

No fundamental analysis for CelLBxHealth plc yet.

CelLBxHealth plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CelLBxHealth plc

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix platform, emables real-time multiomic insights from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and …

Full company profile